Tower View Wealth Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.05K Hold
25
﹤0.01% 175
2026
Q1
$5.37K Hold
25
﹤0.01% 171
2025
Q4
$5.21K Hold
25
﹤0.01% 154
2025
Q3
$3.97K Hold
25
﹤0.01% 158
2025
Q2
$4.23K Hold
25
﹤0.01% 175
2025
Q1
$3.46K Hold
25
﹤0.01% 167
2024
Q4
$2.96K Sell
25
-25
-50% -$2.92K ﹤0.01% 172
2024
Q3
$5.53K Hold
50
﹤0.01% 157
2024
Q2
$4.92K Hold
50
﹤0.01% 156
2024
Q1
$5.59K Sell
50
-17
-25% -$1.83K ﹤0.01% 156
2023
Q4
$7K Hold
67
﹤0.01% 133
2023
Q3
$6K Hold
67
﹤0.01% 131
2023
Q2
$6K Hold
67
﹤0.01% 135
2023
Q1
$5K Hold
67
﹤0.01% 130
2022
Q4
$5K Hold
67
﹤0.01% 137
2022
Q3
$4K Buy
+67
New +$4.25K ﹤0.01% 142
2018
Q4
Sell
-186
Closed -$10K 141
2018
Q3
$10K Hold
186
0.01% 129
2018
Q2
$9K Hold
186
0.01% 119
2018
Q1
$12K Hold
186
0.01% 115
2017
Q4
$11K Buy
+186
New +$11.5K 0.01% 120

Other funds holding CAH

Tower View Wealth Management's CAH Position: Q2 2026 in Review

Tower View Wealth Management held its Cardinal Health (CAH) position steady in Q2 2026 at 25 shares worth $6.05K. The position accounts for ﹤0.01% of the portfolio, ranked #175.

Tower View Wealth Management first reported a position in CAH in Q4 2017 and has held it in 20 quarters since. The position peaked at $12K in Q1 2018. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Tower View Wealth Management held 25 shares of Cardinal Health worth $6.05K as of Q2 2026.
  • Tower View Wealth Management left its Cardinal Health share count unchanged in Q2 2026.
  • Cardinal Health made up ﹤0.01% of Tower View Wealth Management's portfolio in Q2 2026, its #175 holding.
  • Tower View Wealth Management first reported a position in Cardinal Health in Q4 2017 and has held it in 20 quarters since.
  • Tower View Wealth Management's Cardinal Health position peaked at $12K in Q1 2018.
  • 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Tower View Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.